Hope vs. Power: Gene Therapy, FDA Shake-Up, and Truth in Medicine

Hope vs. Power: Gene Therapy, FDA Shake-Up, and Truth in Medicine

Author: The Doctor's Lounge September 4, 2025 Duration: 1:05:38

Send us a text

Original Substack Release: Aug 23, 2025

🎯 Why Listen

When hope collides with billion-dollar incentives, who protects patients? We unpack Vinay Prasad’s FDA resignation, Sarepta’s $3.2M Duchenne gene therapy, and how accelerated approvals can leave families without the long-term data they deserve.


👥 Co-Hosts

  • Dutch Rojas – Founder, Bliksem Health
  • Anthony DiGiorgio, DO, MHA – Neurosurgeon, UCSF; health policy researcher
  • Anish Koka, MD – Cardiologist, Philadelphia; healthcare policy commentator
  • Dan Choi, MD, FAAOS – Orthopedic spine surgeon, Long Island; healthcare advocate and social media voice
  • Sanat Dixit, MD, FACS – Neurosurgeon, Huntsville, AL; Faculty, Vanderbilt University; healthcare entrepreneur

📌 Episode Overview

  • Vinay Prasad’s exit from FDA/CBER and what it signals about evidence, safety, and politics.
  • Duchenne muscular dystrophy, Sarepta’s one-shot gene therapy, and deaths linked to vector toxicity.
  • The promise and peril of accelerated approvals—and why confirmatory trials so often stall.
  • Left vs. right myths about healthcare; markets, incentives, and why “healthcare is a right” can fail in practice.
  • Quick hits: public-good economics in medicine, decentralization vs. central control, and where AI may actually help (RCM, workflow).

💬 Notable Quotes

  • These trials are never gonna get done. It’s a game—with patients as pawns.
  • The FDA is the Midas touch: approval turns hope into revenue—fast.
  • You don’t want a world where healthcare is non-excludable and non-rivalrous.
  • If healthcare is ‘first, do no harm,’ who decides what harm looks like—and who pays the price?


📚 What You’ll Learn

  • How accelerated approval works—and where it breaks.
  • Why safety signals (e.g., vector-related liver failure) matter more than press releases.
  • The difference between hope, evidence, and incentives in rare disease.
  • How political tribes systematically misunderstand healthcare mechanics.
  • Practical places AI can improve care operations today.


The Episode (Timestamps)

  • 00:00–01:10 Welcome back & cadence update (new Sunday drops)
  • 01:10–07:40 Vinay Prasad resigns from FDA/CBER—context and stakes
  • 07:40–13:30 Duchenne 101, dystrophin biology, trial endpoints vs. real outcomes
  • 13:30–17:30 Accelerated approval promises vs. missing confirmatory trials
  • 17:30–22:30 Safety signals: vector immunogenicity, reported deaths, what pulls look like
  • 22:30–28:30 Media/influencer pressure and the politics of “right to try”
  • 28:30–41:30 Is healthcare a public good? Scarcity, incentives, and economic reality
  • 41:30–50:30 Government, morality, and why central planning fails patients
  • 50:30–59:30 AI, agents, and near-term wins in physician workflows
  • 59:30–End What we need next from policymakers—and from clinicians

🔗 Connect with the Hosts:

• Dutch Rojas on X

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

Dr. Sanat Dixit on X


In The Doctor's Lounge, the white coat comes off for a conversation that moves freely from the exam room to the boardroom. This isn't a lecture hall; it's the back table where practicing physicians gather to unpack the complex systems that define modern medicine. Hosted by Dutch Rojas and Anthony DiGiorgio, DO, with regular voices like Anish Koka, MD, Dan Choi, MD, and Sanat Dixit, MD, the discussions are built on frontline experience. You'll hear unfiltered perspectives on the policy debates that shape care, the realities of navigating business and entrepreneurship within a medical practice, and the constant push for meaningful reform. The dialogue is grounded in a shared commitment to physician autonomy and, ultimately, better patient outcomes. Each episode in this podcast connects the dots between clinical fitness and the health of the medical profession itself, offering a rare look at the challenges and opportunities that exist where patient care meets the mechanics of the healthcare industry. It's a space for the nuanced, often contentious, and always real conversations happening behind the scenes.
Author: Language: English Episodes: 49

The Doctor's Lounge
Podcast Episodes
The Shah's Spleen, Quality Metrics, Health Insurance & the FDA [not-audio_url] [/not-audio_url]

Duration: 55:27
Dr. Anish Koka and Dr. Anthony DiGiorgio open with the little-known medical story behind the death of the Shah of Iran — how Mohammed Reza Pahlavi came to be operated on in Cairo in 1980 by legendary cardiovascular surge…
Dr. Mary Talley Bowden Battles the Health System [not-audio_url] [/not-audio_url]

Duration: 58:22
In this conversation, Dr. Mary Talley Bowden shares her experiences as an independent physician during the COVID-19 pandemic, detailing her courageous battle against health systems and the Texas Medical Board. She discus…
NIH Director Jay Bhattacharya [not-audio_url] [/not-audio_url]

Duration: 1:08:13
In this engaging conversation, Dr. Jay Bhattacharya discusses his unique perspective as a health economist and the impact of his training on his approach to public health, particularly during the COVID-19 pandemic. He re…
The $2 Million Verdict: Inside the First Detransition Lawsuit Trial [not-audio_url] [/not-audio_url]

Duration: 1:05:46
Benjamin Ryan was the only journalist in the courtroom for every day of the first detransition lawsuit to reach a jury verdict. In January 2025, a White Plains jury awarded $2 million to Fox Varian, who received a double…